Showing results (21-30 of 429) with videos related to
Sort By:
Pageof 43
Cellular Signalling|January 13, 2017
GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular diseaseAlessandro Cannavo, Walter J KochJournal of Cardiovascular Pharmacology|February 8, 2017
Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-BlockadeAlessandro Cannavo, Walter J KochAssay and Drug Development Technologies|April 20, 2004
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targetsGuido Iaccarino, Walter J KochMolecular Pharmacology|January 6, 2026
GRK2 and GRK5-The 2 critical kinases in cardiac pathophysiologyRajika Roy, Walter J KochJournal of Cardiovascular Translational Research|July 13, 2010
betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart diseaseHenriette Brinks, Walter J KochMethods in Molecular Biology (Clifton, N.J.)|September 23, 2003
In vivo adenoviral-mediated gene transfer of the beta ARKct to study the role of G beta gamma in arterial restenosisGuido Iaccarino, Walter J KochExpert Opinion on Therapeutic Targets|February 1, 2019
GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophyMelissa Lieu, Walter J KochFEBS Letters|February 4, 2014
Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunctionAnagha Sen, Patrick Most, Karsten PeppelCell Calcium|August 22, 2006
S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytesMirko Völkers, Christopher M Loughrey, Niall Macquaide, et al.Circulation|September 6, 2006
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarctionPatrick Most, Hanna Seifert, Erhe Gao, et al.Pageof 43